Similar Papers

Paper Title
Journal
Date
Author
HLA type of patients with coeliac disease and malignancy in the west of Ireland.
B R O'Driscoll ... T A O'Gorman
Gut | VOL. 23
B R O'Driscoll, et. al.B R O'Driscoll ... T A O'Gorman
01 Aug 1982
OR6 Next generation sequencing HLA typing in patients with copy neutral loss of heterozygosity
Fredrick Oakley ... Gansuvd Balgansuren
Human Immunology | VOL. 78
Fredrick Oakley, et. al.Fredrick Oakley ... Gansuvd Balgansuren
01 Sep 2017
P102 Proposed loss of heterozygosity of HLA class I region during acute myelogenous leukemia blast crisis
Michelle J Hickey ... Gary Schiller
Human Immunology | VOL. 78
Michelle J Hickey, et. al.Michelle J Hickey ... Gary Schiller
01 Sep 2017
P234 Typing challenges associated with mixed chimerism
Teri Lynn Steeves ... Kylie Lepic
Human Immunology | VOL. 78
Teri Lynn Steeves, et. al.Teri Lynn Steeves ... Kylie Lepic
01 Sep 2017
View more papers

More From: Human Immunology

Paper Title
Journal
Date
Author
Convalescent COVID-19 monocytes exhibit altered steady-state gene expression and reduced TLR2, TLR4 and RIG-I induced cytokine expression.
Sarah Unterberger ... Sandra Sacre
Human immunology | VOL. 86
Sarah Unterberger, et. al.Sarah Unterberger ... Sandra Sacre
07 Feb 2025
STAT4 gene polymorphism may be associated with microscopic polyangiitis susceptibility in a Chinese Guangxi population: A case-control analysis based on propensity score matching.
Shurong Lu ... Chao Xue
Human immunology | VOL. 86
Shurong Lu, et. al.Shurong Lu ... Chao Xue
24 Jan 2025
CD14++CD16- classical monocyte subset secreting IL-1ß and IL-10 is associated with 'Tuberculosis Resisters' phenotype.
Shaikh Abdul Mubeen ... Archana Singh
Human immunology | VOL. 86
Shaikh Abdul Mubeen, et. al.Shaikh Abdul Mubeen ... Archana Singh
23 Jan 2025
Intradermal lymphocyte therapy: A promising treatment for recurrent pregnancy loss in patients without anti-TPO antibodies.
Rezvan Ebrahimi ... Mehdi Yousefi
Human immunology | VOL. 86
Rezvan Ebrahimi, et. al.Rezvan Ebrahimi ... Mehdi Yousefi
10 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.